Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study
Jianliang Yang, Lihou Dong, Sheng Yang, Xiaohong Han, Ying Han, Shiyu Jiang, Jiarui Yao, Zhishang Zhang, Shuxiang Zhang, Peng Liu, Yan Qin, Hai Wu, Hui Feng, Sheng Yao, Yan Sun, Haifeng Song, Yuankai Shi
Topics & Concepts
MedicineAdverse effectRefractory (planetary science)Internal medicineDosingToxicityResponse Evaluation Criteria in Solid TumorsLymphomaLung cancerGastroenterologySurgeryPhases of clinical researchAstrobiologyPhysicsCancer Immunotherapy and BiomarkersCAR-T cell therapy researchPeptidase Inhibition and Analysis